Dr. Mark J Routbort, MD, PhD - The University of Texas MD Anderson Cancer Center - Director, Computation and Integrational Pathology

Dr. Mark J Routbort

MD, PhD

The University of Texas MD Anderson Cancer Center

Director, Computation and Integrational Pathology

Houston, TX | United States

Main Specialties: Hematology

Additional Specialties: Hematopathology, Informatics

Dr. Mark J Routbort, MD, PhD - The University of Texas MD Anderson Cancer Center - Director, Computation and Integrational Pathology

Dr. Mark J Routbort

MD, PhD

Introduction

Primary Affiliation: The University of Texas MD Anderson Cancer Center - Houston, TX , United States

Specialties:

Additional Specialties:

Publications

21Publications

519Reads

-Profile Views

434PubMed Central Citations

Lung adenocarcinoma with concurrent KRAS mutation and ALK rearrangement responding to crizotinib: case report.

Int J Biol Markers 2015 May 26;30(2):e254-7. Epub 2015 May 26.

1 Department of Medical Oncology, State Oncology Center, ISSEMyM, Toluca - México.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/jbm.5000127DOI Listing
May 2015
20 Reads
1.360 Impact Factor

Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistry.

Am J Surg Pathol 2015 Apr;39(4):454-61

Departments of *Hematopathology †Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000325DOI Listing
April 2015
20 Reads
2 Citations
5.145 Impact Factor

Quantitative assessment of mutant allele burden in solid tumors by semiconductor-based next-generation sequencing.

Am J Clin Pathol 2014 Apr;141(4):559-72

Dept of Hematopathology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 149, Houston, TX 77030; e-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCP1JUGQMW7ZNTLDOI Listing
April 2014
22 Reads
8 Citations
2.514 Impact Factor

Pulmonary granulocytic sarcoma (chloroma) mimicking an opportunistic infection in a patient with acute myeloid leukemia.

Ann Hematol 2014 Feb 30;93(2):327-8. Epub 2013 Apr 30.

Hospital A.C. Camargo, Department of Imaging, Rua Paulo Orozimbo, 726, Aclimação, 01535-001, São Paulo, SP, Brazil,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-013-1768-3DOI Listing
February 2014
15 Reads
1 Citation
2.634 Impact Factor

Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps.

Discov Med 2014 Feb;17(92):101-14

Sheikh Khalifa Al Nahyan Ben Zayed Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160907PMC
February 2014
42 Reads
10 Citations
3.503 Impact Factor

TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.

Am J Hematol 2013 Dec 30;88(12):1055-61. Epub 2013 Sep 30.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Pathology, King Saud University, Riyadh, Saudi Arabia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23567
Publisher Site
http://dx.doi.org/10.1002/ajh.23567DOI Listing
December 2013
23 Reads
13 Citations
3.800 Impact Factor

Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.

J Mol Diagn 2013 Sep 26;15(5):607-22. Epub 2013 Jun 26.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2013.05.003DOI Listing
September 2013
26 Reads
117 Citations
4.851 Impact Factor

Low rates of hepatitis B virus screening at the onset of chemotherapy.

J Oncol Pract 2012 Jul 12;8(4):e32-9. Epub 2012 Jun 12.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2011.000450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396827PMC
July 2012
16 Reads
15 Citations

Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.

Cancer 2012 Mar 31;118(6):1566-73. Epub 2011 Aug 31.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26433DOI Listing
March 2012
2 Reads
14 Citations
4.890 Impact Factor

Tolerance testing of passive radio frequency identification tags for solvent, temperature, and pressure conditions encountered in an anatomic pathology or biorepository setting.

J Pathol Inform 2010 Oct 1;1:21. Epub 2010 Oct 1.

Department of Pathology and Laboratory Medicine (Neuropathology), David Geffen School of Medicine at UCLA, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2153-3539.70710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956174PMC
October 2010
28 Reads
4 Citations

The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death.

Apoptosis 2009 Apr;14(4):336-47

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10495-009-0327-9DOI Listing
April 2009
5 Reads
17 Citations
3.685 Impact Factor

Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms.

Am J Surg Pathol 2008 Sep;32(9):1299-309

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e318165eb50DOI Listing
September 2008
1 Read
31 Citations
5.145 Impact Factor

Primary adrenal natural killer/T-cell nasal type lymphoma: first case report in adults.

Am J Hematol 2007 Apr;82(4):299-303

Division of Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.20811DOI Listing
April 2007
3 Reads
3 Citations
3.800 Impact Factor

Pancreatic and bile duct brushing cytology in 1000 cases: review of findings and comparison of preparation methods.

Cancer 2006 Aug;108(4):231-8

Department of Pathology, University of North Carolina, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21842DOI Listing
August 2006
11 Reads
14 Citations
4.890 Impact Factor

Primary pancreatic lymphoma evaluated by fine-needle aspiration: findings in 14 cases.

Am J Clin Pathol 2004 Jun;121(6):898-903

Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/UAD9-PYFU-A82X-9R9UDOI Listing
June 2004
2 Reads
10 Citations
2.514 Impact Factor

Top co-authors

Rajyalakshmi Luthra
Rajyalakshmi Luthra

The University of Texas MD Anderson Cancer Center

9
Keyur P Patel
Keyur P Patel

The University of Texas MD Anderson Cancer Center

9
Rajesh R Singh
Rajesh R Singh

The University of Texas MD Anderson Cancer Center

6
Rashmi Kanagal-Shamanna
Rashmi Kanagal-Shamanna

The University of Texas MD Anderson Cancer Center

5
Funda Meric-Bernstam
Funda Meric-Bernstam

The University of Texas MD Anderson Cancer Center

4
Bedia A Barkoh
Bedia A Barkoh

The University of Texas MD Anderson Cancer Center

4
Kenneth D Aldape
Kenneth D Aldape

The University of Texas MD Anderson Cancer Center

4
Neelima G Reddy
Neelima G Reddy

Baylor College of Medicine

3
John Mendelsohn
John Mendelsohn

The University of Texas MD Anderson Cancer Center

3
Gordon B Mills
Gordon B Mills

The University of Texas MD Anderson Cancer Center

3